— Veru Inc. (NASDAQ: VERU) reported Q1 2020 loss of $0.05 per share, vs. $0.02 expected.
— Revenues grew 66% to $10.6 million, vs. $8.7 million expected.
— FC2 US prescription net revenues increased 148% to $6.1 million.
— Gross profit increased 57% to $7.3 million.
— VERU shares were up 3.7% in premarket hours on Wednesday.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Cost reduction has become a priority for FedEx (FDX) after a challenging quarter
Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for
Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know
After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG
Stock Watch: Is Darden Restaurants a good buy after earnings?
After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many
